What is RFXCEL?
Founded in 2003 and headquartered in Reno, Nevada, RFXCEL specializes in pharmaceutical supply chain safety, offering advanced track-and-trace software solutions. Its technology serves manufacturers, re-packagers, wholesalers, distributors, and dispensers, aiming to enhance the integrity and security of pharmaceutical products throughout the supply chain. This focus positions RFXCEL as a critical player in regulatory compliance and product keamanan within the healthcare industry.
How much funding has RFXCEL raised?
RFXCEL has raised a total of $30M across 1 funding round:
Series B
$30M
Series B (2017): $30M with participation from Kayne Partners
Key Investors in RFXCEL
Kayne Partners
Kayne Partners, part of Kayne Anderson Capital Advisors, is an investment firm with a focus on growth equity, energy, infrastructure, real estate, and credit. Their involvement suggests a strategic interest in RFXCEL's expansion and market penetration.
What's next for RFXCEL?
The substantial enterprise-level backing, including the recent strategic investment, indicates a strong confidence in RFXCEL's business model and future prospects. This capital infusion is likely to fuel further development of its track-and-trace software, expansion into new markets, and enhancement of its service offerings to meet evolving regulatory demands and industry needs. RFXCEL is poised to strengthen its leadership in ensuring pharmaceutical supply chain integrity.
See full RFXCEL company page
